169 related articles for article (PubMed ID: 37188573)
1. A people-centered decentralized outreach model toward HCV micro-elimination in hyperendemic areas: COMPACT study in SARS Co-V2 pandemic.
Huang CI; Liang PC; Wei YJ; Tsai PC; Hsu PY; Hsieh MY; Liu TW; Lin YH; Hsieh MH; Jang TY; Wang CW; Yang JF; Yeh ML; Huang CF; Dai CY; Chuang WL; Huang JF; Yu ML
J Microbiol Immunol Infect; 2023 Jun; 56(3):586-597. PubMed ID: 37188573
[TBL] [Abstract][Full Text] [Related]
2. Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison.
Chen CT; Lu MY; Hsieh MH; Tsai PC; Hsieh TY; Yeh ML; Huang CI; Tsai YS; Ko YM; Lin CC; Chen KY; Wei YJ; Hsu PY; Hsu CT; Jang TY; Liu TW; Liang PC; Hsieh MY; Lin ZY; Huang CF; Huang JF; Dai CY; Chuang WL; Shih YL; Yu ML
World J Gastroenterol; 2022 Jan; 28(2):263-274. PubMed ID: 35110949
[TBL] [Abstract][Full Text] [Related]
3. Micro-elimination of hepatitis C virus infection in the rural and remote areas of Taiwan - A multi-center collaborative care model.
Lo CC; Lei WY; Huang YC; Hwang JJ; Lo CY; Lin CH; Cheng HS; Liao YT; Liang PC; Chiou MJ; Bair MJ; Dai CY; Yu ML
J Microbiol Immunol Infect; 2023 Aug; 56(4):680-687. PubMed ID: 36822945
[TBL] [Abstract][Full Text] [Related]
4. Liver Disease Screening and Hepatitis C Virus Elimination in Taiwan Rural Indigenous Townships: Village-By-Village Screening and Linking to Outreach Hepatology Care.
Tien HM; Cheng TC; Lien HC; Yang KF; Shy CG; Chen YL; Hsu NT; Lu SN; Wang JH
Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35328957
[TBL] [Abstract][Full Text] [Related]
5. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan.
Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC
World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032
[TBL] [Abstract][Full Text] [Related]
6. Low disease awareness as a contributing factor to the high prevalence of hepatitis C infection in Tzukuan, a hyperendemic area of southern Taiwan.
Tsai PC; Dai CY; Huang CI; Yeh ML; Huang CF; Hsieh MH; Yang JF; Hsu PY; Liang PC; Lin YH; Jang TY; Hsieh MY; Lin ZY; Chen SC; Huang JF; Yu ML; Chuang WL; Chang WY
Kaohsiung J Med Sci; 2022 Jul; 38(7):694-702. PubMed ID: 35485737
[TBL] [Abstract][Full Text] [Related]
7. Collaborative Referral Model to Achieve Hepatitis C Micro-Elimination in Methadone Maintenance Treatment Patients during the COVID-19 Pandemic.
Tai CM; Huang CK; Changchien TC; Lin PC; Wang DW; Chang TT; Chan HW; Chen TH; Tseng CH; Chen CC; Tsai CT; Sie YT; Yen YC; Yu ML
Viruses; 2022 Jul; 14(8):. PubMed ID: 35893702
[TBL] [Abstract][Full Text] [Related]
8. Treating people where they are: Nurse-led micro-elimination of hepatitis C in supported housing sites for networks of people who inject drugs in Victoria, Canada.
Selfridge M; Barnett T; Lundgren K; Guarasci K; Milne R; Drost A; Fraser C
Public Health Nurs; 2022 Sep; 39(5):1009-1016. PubMed ID: 35537120
[TBL] [Abstract][Full Text] [Related]
9. Establishment of an outreach, grouping healthcare system to achieve microelimination of HCV for uremic patients in haemodialysis centres (ERASE-C).
Yu ML; Huang CF; Wei YJ; Lin WY; Lin YH; Hsu PY; Hsu CT; Liu TW; Lee JJ; Niu SW; Huang JC; Hung TS; Yeh ML; Huang CI; Liang PC; Hsieh MY; Chen SC; Huang JF; Chang JM; Chiu YW; Dai CY; Hwang SJ; Chuang WL;
Gut; 2021 Dec; 70(12):2349-2358. PubMed ID: 33303567
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and Treatment Rate of Patients With Hepatitis C Virus Infection in the Direct-Acting Antiviral Era and During the COVID-19 Pandemic in the United States.
Nguyen VH; Kam L; Yeo YH; Huang DQ; Henry L; Cheung R; Nguyen MH
JAMA Netw Open; 2022 Dec; 5(12):e2245424. PubMed ID: 36477481
[TBL] [Abstract][Full Text] [Related]
11. Patient-centered and integrated outreach care for chronic hepatitis C patients with serious mental illness in Taiwan.
Huang CF; Jang TY; Yu SC; Huang SC; Ho SL; Yeh ML; Wang CW; Liang PC; Wei YJ; Hsu PY; Huang CI; Hsieh MY; Lin YH; Yu SL; Wu PF; Chen YH; Chien SC; Huang JF; Dai CY; Chuang WL; Wang TJ; Yu ML
Kaohsiung J Med Sci; 2024 Jan; 40(1):86-93. PubMed ID: 37942784
[TBL] [Abstract][Full Text] [Related]
12. Community-based screening by Anti-HCV reflex HCV Ag test and accessible post-screening care toward elimination of hepatitis C in two hyperendemic townships.
Kee KM; Chen WM; Hsu NT; Wang JH; Chao WH; Lin YC; Lu SN
J Formos Med Assoc; 2022 Sep; 121(9):1850-1856. PubMed ID: 35339312
[TBL] [Abstract][Full Text] [Related]
13. Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era.
Hariri S; Sharafi H; Sheikh M; Merat S; Hashemi F; Azimian F; Tamadoni B; Ramazani R; Gouya MM; Abbasi B; Tashakorian M; Alasvand R; Alavian SM; Poustchi H; Malekzadeh R
Harm Reduct J; 2020 Oct; 17(1):80. PubMed ID: 33081794
[TBL] [Abstract][Full Text] [Related]
14. Moving Towards Hepatitis C Microelimination Among People Living With Human Immunodeficiency Virus in Australia: The CEASE Study.
Martinello M; Yee J; Bartlett SR; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Lin L; Marks P; Applegate T; Dore GJ; Matthews GV
Clin Infect Dis; 2020 Sep; 71(6):1502-1510. PubMed ID: 31585005
[TBL] [Abstract][Full Text] [Related]
15. Implementation of a decentralized hepatitis C care pathway for people who use drugs in Dutch addiction care. Study protocol for the Hepatitis C: chain of addiction care (CAC) project.
Von den Hoff DW; Berden FAC; Drenth JPH; Schellekens AFA;
Addict Sci Clin Pract; 2022 Nov; 17(1):67. PubMed ID: 36451175
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C care cascade before and during the direct-acting antiviral eras in New South Wales, Australia: A population-based linkage study.
Yousafzai MT; Alavi M; Valerio H; Hajarizadeh B; Grebely J; Dore GJ
J Viral Hepat; 2023 Mar; 30(3):250-261. PubMed ID: 36537024
[TBL] [Abstract][Full Text] [Related]
17. [Elimination of hepatitis C virus in Denmark].
Døssing A; Røge BT; Madsen LG; Laursen AL; Hansen JB; Bukh J; Weis N
Ugeskr Laeger; 2020 Feb; 182(9):. PubMed ID: 32138816
[TBL] [Abstract][Full Text] [Related]
18. Collaborative Referral Model for Hepatitis C Screening and Treatment in a Remote Mountainous Region of Taiwan during the COVID-19 Pandemic.
Tai CM; Bair MJ; Chen TH; Tseng CH; Chen CC; Lam H; Yu ML
Viruses; 2023 Mar; 15(4):. PubMed ID: 37112808
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus (HCV) micro-elimination in the hospital setting: The results of the HCV Caserta hospital project.
Messina V; Pisaturo M; Alessio L; Russo A; Tripaldelli E; Petruzziello A; Annecchiarico A; Romano MR; Maggi P; Coppola N
J Infect Public Health; 2022 May; 15(5):562-565. PubMed ID: 35461078
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of the CT2 study: A 'one-stop-shop' for community-based hepatitis C testing and treatment in Yangon, Myanmar.
Draper BL; Htay H; Pedrana A; Yee WL; Howell J; Pyone Kyi K; Naing W; Sanda Aung K; Markby J; Easterbrook P; Bowring A; Aung W; Sein YY; Nwe N; Myint KT; Shilton S; Hellard M
Liver Int; 2021 Nov; 41(11):2578-2589. PubMed ID: 34153155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
